中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
Evaluation and Analysis of Drug-Use in Hospitals of China
2015年
8期
1109-1111
,共3页
医嘱审核%合理用药%干预
醫囑審覈%閤理用藥%榦預
의촉심핵%합리용약%간예
Examination of medical orders%Rational drug use%Intervene
目的:了解上海市松江区中心医院(以下简称"我院")住院患者口服用药情况,为临床合理用药提供参考. 方法:通过我院信息系统抽取2014年住院患者口服用药长期医嘱707 624份,对医嘱的审核结果及干预情况进行统计分析. 结果:707 624份住院患者口服用药医嘱中,不合理医嘱816份,医嘱不合理率为0. 12%. 干预被采纳医嘱504份,采纳率为61. 76%,其中用法、用量不合理(173份,占34. 26%),重复给药(144份,占28. 52%)及联合用药不合理(187份,37. 030%). 结论:药师参与药物治疗过程,对医嘱进行审核干预,有利于提高合理用药水平,保证患者安全、有效、经济用药.
目的:瞭解上海市鬆江區中心醫院(以下簡稱"我院")住院患者口服用藥情況,為臨床閤理用藥提供參攷. 方法:通過我院信息繫統抽取2014年住院患者口服用藥長期醫囑707 624份,對醫囑的審覈結果及榦預情況進行統計分析. 結果:707 624份住院患者口服用藥醫囑中,不閤理醫囑816份,醫囑不閤理率為0. 12%. 榦預被採納醫囑504份,採納率為61. 76%,其中用法、用量不閤理(173份,佔34. 26%),重複給藥(144份,佔28. 52%)及聯閤用藥不閤理(187份,37. 030%). 結論:藥師參與藥物治療過程,對醫囑進行審覈榦預,有利于提高閤理用藥水平,保證患者安全、有效、經濟用藥.
목적:료해상해시송강구중심의원(이하간칭"아원")주원환자구복용약정황,위림상합리용약제공삼고. 방법:통과아원신식계통추취2014년주원환자구복용약장기의촉707 624빈,대의촉적심핵결과급간예정황진행통계분석. 결과:707 624빈주원환자구복용약의촉중,불합리의촉816빈,의촉불합리솔위0. 12%. 간예피채납의촉504빈,채납솔위61. 76%,기중용법、용량불합리(173빈,점34. 26%),중복급약(144빈,점28. 52%)급연합용약불합리(187빈,37. 030%). 결론:약사삼여약물치료과정,대의촉진행심핵간예,유리우제고합리용약수평,보증환자안전、유효、경제용약.
OBJECTIVE:To probe into the oral medication of inpatients in the Center Hospital of Shanghai Songjiang Distinct ( hereinafter referred to as "our hospital") , and to provide reference for clinical rational drug use. METHODS:707624 standing orders of oral medication of inpatients in 2014 were extracted through HIS system in our hospital, the audits results and intervention situation of orders were statistically analyzed. RESULTS: Of the 707 624 orders, 816 orders were unreasonable, accounting for 0. 12%. Interventions were adopted by 504 orders and accounting for 61. 76%. The mainly irrational types were improper drug dosage ( 173 orders, 34. 26%) , repeated administration ( 144 orders, 28. 52%) and unreasonable combination therapy ( 187 orders, 37. 03%) . CONCLUSIONS:Pharmacists' participation in the medication therapy and intervention of orders can improve the level of rational drug use and ensure safe,effective and economic drug use for patients.
